DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 164 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $68,000 | -79.3% | 4,304 | -78.9% | 0.00% | – |
Q4 2023 | $329,000 | +122.3% | 20,419 | +74.6% | 0.00% | – |
Q3 2023 | $148,000 | +29.8% | 11,697 | +44.5% | 0.00% | – |
Q2 2023 | $114,000 | +17.5% | 8,095 | +29.1% | 0.00% | – |
Q1 2023 | $97,000 | -34.0% | 6,271 | -30.3% | 0.00% | – |
Q4 2022 | $147,000 | +1370.0% | 8,998 | +1492.6% | 0.00% | – |
Q3 2022 | $10,000 | +233.3% | 565 | +123.3% | 0.00% | – |
Q2 2022 | $3,000 | -87.0% | 253 | -89.6% | 0.00% | – |
Q1 2022 | $23,000 | -72.3% | 2,443 | -71.3% | 0.00% | – |
Q4 2021 | $83,000 | +361.1% | 8,523 | +1542.2% | 0.00% | – |
Q3 2021 | $18,000 | +800.0% | 519 | +1053.3% | 0.00% | – |
Q2 2021 | $2,000 | -97.9% | 45 | -97.9% | 0.00% | – |
Q1 2021 | $97,000 | +9600.0% | 2,164 | +8556.0% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 25 | -28.6% | 0.00% | – |
Q2 2020 | $2,000 | -95.1% | 35 | -96.5% | 0.00% | – |
Q1 2020 | $41,000 | -66.1% | 1,010 | -48.2% | 0.00% | – |
Q4 2019 | $121,000 | +1412.5% | 1,948 | +471.3% | 0.00% | – |
Q2 2019 | $8,000 | -20.0% | 341 | +28.2% | 0.00% | – |
Q3 2018 | $10,000 | +400.0% | 266 | +358.6% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 58 | -28.4% | 0.00% | – |
Q4 2017 | $2,000 | – | 81 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |